Global Healthcare ETF - Currency Hedged

OVERVIEW

About

Provides simple, cost-effective and transparent exposure to the largest companies in the global healthcare sector

Tactical exposure to the global healthcare sector
A core component of a global equities allocation providing transparency and diversification benefits

Advantages

Access – simple way to access a diversified portfolio of the world’s largest healthcare companies
Reduced currency risk – foreign currency exposure hedged to the Australian dollar
Diversification – with a single trade, investors can get exposure to a diversified portfolio of healthcare companies from a broad range of global locations
Cost effective – Fund aims to track the performance of an index (no ‘active manager’ fees)
Large company exposure – strategy invests only in the most significant healthcare companies globally
No W-8 BEN forms and no US estate tax implications for investors – simplified tax administration, unlike cross-listed alternatives
Liquidity – available to trade on ASX like any share

How to Invest

You can buy or sell units just like you’d buy or sell any share on the ASX
Fund requires no minimum investment

CLOSE

KEY FACTS

Pricing Information 17 July 2018

Current Price
Last Trade*	$5.67
% Change (prev day)	1.61%
Bid (delayed)	$5.66
Offer (delayed)	$5.95

*Data is delayed by at least 20 minutes.

Download NAV history

NAV
NAV/Unit *	$5.64

* As at 16 July 2018

Profile

Net Assets* ($A)	$24,830,401
Units Outstanding* (#)	4,400,450
Mgmt Costs** (% p.a.)	0.57%
Distribution Frequency	Semi-annual
Distribution Reinvestment Plan (DRP)	Full or partial participation available
Issuer	BetaShares Capital Ltd
Fund Administrator	RBC Investor Services
Custodian	RBC Investor Services
Registry	Link Market Services
Auditor	KPMG

* As at 16 July 2018

**Certain additional costs apply. Please refer to PDS.

Trading Information

ASX Code	DRUG
Bloomberg Code	DRUG AU
IRESS Code	DRUG.AXW
Trading Hours	10.00-16.00 (AEST)
iNAV IRESS Code	N/A
Market Makers	Deutsche Securities
SMSF Eligible	Yes

Index Information

Index	Nasdaq Global ex-Australia Healthcare Hedged AUD Index
Index Provider	Nasdaq
Index Ticker	N/A
Bloomberg Index Ticker	NQXAUHHN INDEX

Index Methodology

Top Exposures

Name	%
Johnson & Johnson	8.1 %
UnitedHealth Group Inc	5.9 %
Pfizer Inc	5.7 %
Novartis AG	5.3 %
Roche Holding AG	4.4 %
Merck & Co Inc	4.0 %
AbbVie Inc	3.4 %
Medtronic PLC	3.1 %
Abbott Laboratories	2.7 %
GlaxoSmithKline PLC	2.6 %

As of close of trading 30/06/2018

The information above shows underlying share exposures of the Fund.

Sector Allocation

Healthcare

100.0%

* As of 30 June 2018

Country Allocation

United States	68.9%
Switzerland	10.5%
Britain	5.0%
Japan	4.3%
Germany	3.9%
France	3.2%
Denmark	2.3%
Netherlands	1.1%
South Korea	0.7%

* As of 30 June 2018

CLOSE

PERFORMANCE

Fund Returns After Fees (%)

	Fund	Index
1 month	1.79%	1.83%
3 months	4.24%	4.33%
6 months	1.70%	1.67%
1 year	5.57%	5.87%
3 year p.a	-	-
5 year p.a	-	-
Since inception (p.a)	6.16%	6.50%
Inception date	4-Aug-16	-

* As at 30 June 2018

Chart

Past performance is not an indicator of future performance. Returns are calculated in Australian dollars using net asset value per unit at the start and end of the specified period and do not reflect brokerage or the bid ask spread that investors incur when buying and selling units on the ASX. Returns are after fund management costs, assume reinvestment of any distributions and do not take into account tax paid as an investor in the Fund. Returns for periods longer than one year are annualised. Current performance may be higher or lower than the performance shown.

CLOSE

DISTRIBUTIONS

Yield Information

Distribution Frequency	Semi-Annual
12 Mth Distribution Yield* (%)	0.3%
12 Mth Gross Distribution Yield* (%)	-
Franking Level	-

* As of 30 June 2018. Yield figures are calculated by summing the prior 12 month fund per unit distributions divided by the fund closing NAV per unit at quarter-end. Past performance is not an indicator of future performance.

Recent Distributions

Ex Date	Record Date	Payment Date	Distribution Unit ($)	Annual Distribution Return (%) (1)
-	-	-	-	-

¹ This is the annual distribution return to the end of the relevant distribution date. The distribution return reflects the contribution to total investment return made by the Fund's distributions. It is calculated as the difference between total Fund return and NAV return. NAV return is the change in the Fund's NAV price. Total return is the NAV return plus reinvestment of all distributions back to the Fund. Past performance not indicative of future performance.

CLOSE

ANNOUNCEMENTS

ASX Announcements: DRUG

Download

Showing - of

CLOSE

RESOURCES

	Factsheet - DRUG	Download
	The Investment Case for DRUG	Download
	Portfolio Holdings	Download
	Index Methodology	Download
	Notice of Proposed Modifications to Fund Constitution – AMIT Tax Regime	Download
	NRWT and Fund Payment Notice information – June 2018 distributions	Download
	Annual Report - June 2017	Download
	Product Disclosure Statement - Global Sector Series	Download
	NRWT and Fund Payment Notice information – December 2017 distributions	Download
	2018 Distribution Calendar	Download
	Interim Financial Report	Download

CLOSE

RELATED FUNDS

FUEL

Global Energy Companies ETF - Currency Hedged

Learn more

HACK

Global Cybersecurity ETF

Learn more

DRUG

BetaShares Global Healthcare ETF - Currency Hedged

OVERVIEW

About

Advantages

How to Invest

KEY FACTS

Pricing Information 17 July 2018

Profile

Trading Information

Index Information

Top Exposures

Sector Allocation

Country Allocation

PERFORMANCE

Fund Returns After Fees (%)

Chart

DISTRIBUTIONS

Yield Information

Recent Distributions

ANNOUNCEMENTS

ASX Announcements: DRUG

RESOURCES

RELATED FUNDS

FUEL

HACK

RECENTLY VIEWED

LEARN MORE ABOUT DRUG